N-methylquipazine: Carbon-11 labelling of the 5-HT3 agonist and in vivo evaluation of its biodistribution using PET
โ Scribed by Jan-Olov Thorell; Sharon Stone-Elander; Lars Eriksson; Martin Ingvar
- Book ID
- 117688244
- Publisher
- Elsevier Science
- Year
- 1997
- Tongue
- English
- Weight
- 743 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0969-8051
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
In this study, we examined the effect of n-methylquipazine (NMQ), which is a putative 5-hydr~xytryptamine~ (5-HT3) receptor agonist, on the extracellular concentrations of dopamine (DA) and one of its metabolites, dihydroxyphenylacetic acid (DOPAC), in the anterior medial prefrontal cortex (AmPFc) o
## Abstract Sumitriptan (1), a nonโselective 5โHT~1B/1D~ agonist is an effective therapeutic agent for the acute treatment of migraine, but it is contraindicated for use in patients with known heart disease. The first Selective Serotonin One F Receptor Agonist (SSOFRA), 5โ(4โฒโfluorobenzโamido)โ3โ(_